# OnCo record andrew-wagner (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/andrew-wagner/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "andrew-wagner" ;
  schema:name "Andrew J. Wagner"@en ;
  schema:description "Boston sarcoma doctor who first showed that mTOR inhibitors shrink perivascular epithelioid cell tumours and then led AMPECT, the trial that made nab-sirolimus the first approved treatment for these rare cancers."@en ;
  schema:url <https://onco.cc/people/andrew-wagner/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "sarcoma", "rare-cancers", "targeted-therapy", "trialist" ;
  schema:jobTitle "Sarcoma medical oncologist, Dana-Farber Cancer Institute" ;
  onco:cancers <https://onco.cc/cancers/pecoma/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ampect-nab-sirolimus-pecoma-wagner-jco-2021/>, <https://onco.cc/key-papers/paper-wagner-sirolimus-pecoma-jco-2010/> ;
  schema:affiliation <https://onco.cc/institutions/dana-farber/> .